Company intelligence / Profile preview

XIO Group

London, United Kingdom

Ownership: Private
Employees: ~70
Development stage: Other

Overview

XIO Group is a global multi-billion dollar alternative investments and private equity firm. It specializes in identifying and investing in market-leading businesses across North America and Europe, helping them capitalize on opportunities in fast-growing markets, particularly in Asia. The firm had over $3.2 billion in committed capital and an international team of more than 70 professionals. Key healthcare investments included Lumenis (medical laser devices).

Therapeutic areas: OtherOphthalmologyDermatology
Modalities: LaserIntense Pulsed Light (IPL)Radio-Frequency (RF)
Industry: Investors

Beyond the preview

Go deeper on XIO Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on XIO Group.

Explore the full profile